![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
MA Hebert, CG Van Horne, BJ Hoffer and GA Gerhardt
Neuroscience Training Program, University of Colorado Health Sciences Center Denver, USA.
The functional effects of a single dual-site intranigral administration (10 micrograms) of glial cell line-derived neurotrophic factor (GDNF) on dopamine (DA) neurons in the basal ganglia of young Fischer 344 rats were investigated. A combination of behavioral, in vivo electrochemical, microdialysis and high-performance liquid chromatography methods were used to study the effects of this novel peptide. Behaviorally, significant changes in spontaneous locomotor activity were found 1 week, but not 3 weeks, after GDNF treatment. However, the velocity of movements was increased in the GDNF-treated animals 3 weeks after GDNF administration, a result that corresponded to significant enhancement of stimulus-evoked release of DA. Two-fold increases in potassium-evoked DA overflow were seen throughout the striatum by means of high-speed chronoamperometry 3 weeks after GDNF injection. No significant change in basal levels of DA was measured by microdialysis, although both potassium-evoked and d-amphetamine-induced DA overflow were significantly increased 3 weeks after treatment. Finally, significant changes in whole-tissue levels of DA were seen in the substantia nigra 1 week, but not 3 weeks, after GDNF administration. These data represent the first studies demonstrating that GDNF has long-lasting functional presynaptic effects on DA- containing neurons in the rat striatum.
This article has been cited by other articles:
|
|
 |
|
  D. N. Hovland Jr., R. B. Boyd, M. T. Butt, J. A. Engelhardt, M. S. Moxness, M. H. Ma, M. G. Emery, N. B. Ernst, R. P. Reed, J. R. Zeller, et al. Reprint: Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys Toxicol Pathol, December 1, 2007; 35(7): 1013 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Hovland Jr., R. B. Boyd, M. T. Butt, J. A. Engelhardt, M. S. Moxness, M. H. Ma, M. G. Emery, N. B. Ernst, R. P. Reed, J. R. Zeller, et al. Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys Toxicol Pathol, August 1, 2007; 35(5): 676 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Rind, R. Butowt, and C. S. von Bartheld Synaptic Targeting of Retrogradely Transported Trophic Factors in Motoneurons: Comparison of Glial Cell Line-Derived Neurotrophic Factor, Brain-Derived Neurotrophic Factor, and Cardiotrophin-1 with Tetanus Toxin J. Neurosci., January 19, 2005; 25(3): 539 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Georgievska, D. Kirik, and A. Bjorklund Overexpression of Glial Cell Line-Derived Neurotrophic Factor Using a Lentiviral Vector Induces Time- and Dose-Dependent Downregulation of Tyrosine Hydroxylase in the Intact Nigrostriatal Dopamine System J. Neurosci., July 21, 2004; 24(29): 6437 - 6445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Doxakis, S Wyatt, and A. Davies Depolarisation causes reciprocal changes in GFR(alpha)-1 and GFR(alpha)-2 receptor expression and shifts responsiveness to GDNF and neurturin in developing neurons Development, January 4, 2000; 127(7): 1477 - 1487. [Abstract] [PDF]
|
|
|
|
|
|
B. A. Horger, C. A. Iyasere, M. T. Berhow, C. J. Messer, E. J. Nestler, and J. R. Taylor Enhancement of Locomotor Activity and Conditioned Reward to Cocaine by Brain-Derived Neurotrophic Factor J. Neurosci., May 15, 1999; 19(10): 4110 - 4122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Cass and M. W. Manning GDNF Protection against 6-OHDA-Induced Reductions in Potassium-Evoked Overflow of Striatal Dopamine J. Neurosci., February 15, 1999; 19(4): 1416 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Hebert and G. A. Gerhardt Age-Related Changes in the Capacity, Rate, and Modulation of Dopamine Uptake within the Striatum and Nucleus Accumbens of Fischer 344 Rats: An In Vivo Electrochemical Study J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 879 - 887. [Abstract] [Full Text]
|
|
|
|
|
|
A. F. Hoffman, C. R. Lupica, and G. A. Gerhardt Dopamine Transporter Activity in the Substantia Nigra and Striatum Assessed by High-Speed Chronoamperometric Recordings in Brain Slices J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 487 - 496. [Abstract] [Full Text]
|
|
|
|
|
|
B. A. Horger, M. C. Nishimura, M. P. Armanini, L.-C. Wang, K. T. Poulsen, C. Rosenblad, D. Kirik, B. Moffat, L. Simmons, E. Johnson Jr, et al. Neurturin Exerts Potent Actions on Survival and Function of Midbrain Dopaminergic Neurons J. Neurosci., July 1, 1998; 18(13): 4929 - 4937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. N. Pothos, V. Davila, and D. Sulzer Presynaptic Recording of Quanta from Midbrain Dopamine Neurons and Modulation of the Quantal Size J. Neurosci., June 1, 1998; 18(11): 4106 - 4118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Kearns, W. A. Cass, K. Smoot, R. Kryscio, and D. M. Gash GDNF Protection against 6-OHDA: Time Dependence and Requirement for Protein Synthesis J. Neurosci., September 15, 1997; 17(18): 7111 - 7118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Hebert and G. A. Gerhardt Behavioral and Neurochemical Effects of Intranigral Administration of Glial Cell Line-Derived Neurotrophic Factor on Aged Fischer 344 Rats J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 760 - 768. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
